• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Cannabis Stock Movers For July 12, 2024

    7/12/24 4:30:05 PM ET
    $CARA
    $CRBP
    $EAST
    $GENE
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $CARA alert in real time by email

    GAINERS:

    • Zelira Therapeutics (OTC:ZLDAF) shares closed up 69.95% at $0.48
    • Global Hemp Group (OTC:GBHPF) shares closed up 40.00% at $0.03
    • CordovaCann (OTC:LVRLF) shares closed up 29.03% at $0.04
    • Elixinol Wellness (OTC:ELLXF) shares closed up 25.00% at $0.00
    • Eastside Distilling (NASDAQ:EAST) shares closed up 23.57% at $1.20
    • Body and Mind (OTC:BMMJ) shares closed up 15.70% at $0.04
    • Pharmadrug (OTC:LMLLF) shares closed up 15.25% at $0.01
    • 1933 Industries (OTC:TGIFF) shares closed up 14.86% at $0.01
    • Maple Leaf Green World (OTC:MGWFF) shares closed up 10.69% at $0.03
    • Corbus Pharmaceuticals (NASDAQ:CRBP) shares closed up 10.42% at $58.92
    • Rocky Mountain High (OTC:RMHB) shares closed up 8.33% at $0.01
    • Village Farms Intl (NASDAQ:VFF) shares closed up 8.18% at $1.07
    • Greenlane Hldgs (NASDAQ:GNLN) shares closed up 7.67% at $0.28
    • Urban-gro (NASDAQ:UGRO) shares closed up 5.48% at $1.50
    • Mexco Energy (AMEX:MXC) shares closed up 5.00% at $11.98
    • MariMed (OTC:MRMD) shares closed up 4.94% at $0.17
    • 22nd Century Group (NASDAQ:XXII) shares closed up 4.42% at $0.86
    • Charlottes Web Holdings (OTC:CWBHF) shares closed up 3.69% at $0.17

    LOSERS:

    • CLS Holdings USA (OTC:CLSH) shares closed down 27.84% at $0.04
    • Genetic Technologies (NASDAQ:GENE) shares closed down 24.32% at $0.80
    • Target Group (OTC:CBDY) shares closed down 12.33% at $0.00
    • Cansortium (OTC:CNTMF) shares closed down 10.87% at $0.10
    • 4Front Ventures (OTC:FFNTF) shares closed down 7.18% at $0.09
    • Global Compliance (OTC:FUAPF) shares closed down 4.70% at $0.01
    • iAnthus Capital Hldgs (OTC:ITHUF) shares closed down 4.17% at $0.02
    • CNBX Pharmaceuticals (OTC:CNBX) shares closed down 4.05% at $0.01
    • Cara Therapeutics (NASDAQ:CARA) shares closed down 3.28% at $0.35

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $CARA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CARA
    $CRBP
    $EAST
    $GENE

    CompanyDatePrice TargetRatingAnalyst
    Corbus Pharmaceuticals Holdings Inc.
    $CRBP
    7/30/2025$28.00Buy
    B. Riley Securities
    Corbus Pharmaceuticals Holdings Inc.
    $CRBP
    2/28/2025Outperform
    William Blair
    Corbus Pharmaceuticals Holdings Inc.
    $CRBP
    12/2/2024Overweight
    Piper Sandler
    Corbus Pharmaceuticals Holdings Inc.
    $CRBP
    7/30/2024$85.00Outperform
    Wedbush
    Corbus Pharmaceuticals Holdings Inc.
    $CRBP
    7/22/2024$80.00Buy
    H.C. Wainwright
    Corbus Pharmaceuticals Holdings Inc.
    $CRBP
    6/26/2024$85.00Buy
    B. Riley Securities
    Cara Therapeutics Inc.
    $CARA
    6/13/2024$6.00 → $1.00Buy → Hold
    Stifel
    Cara Therapeutics Inc.
    $CARA
    6/13/2024$10.00 → $1.00Buy → Hold
    Canaccord Genuity
    More analyst ratings

    $CARA
    $CRBP
    $EAST
    $GENE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    B. Riley Securities resumed coverage on Corbus Pharma with a new price target

    B. Riley Securities resumed coverage of Corbus Pharma with a rating of Buy and set a new price target of $28.00

    7/30/25 8:22:15 AM ET
    $CRBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    William Blair initiated coverage on Corbus Pharma

    William Blair initiated coverage of Corbus Pharma with a rating of Outperform

    2/28/25 7:22:12 AM ET
    $CRBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Piper Sandler initiated coverage on Corbus Pharma

    Piper Sandler initiated coverage of Corbus Pharma with a rating of Overweight

    12/2/24 9:55:40 AM ET
    $CRBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CARA
    $CRBP
    $EAST
    $GENE
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 23, 2021 - FDA Authorizes Marketing of Tobacco Products that Help Reduce Exposure to and Consumption of Nicotine for Smokers Who Use Them

    For Immediate Release: December 23, 2021 Today, the U.S. Food and Drug Administration authorized the marketing of 22nd Century Group Inc.’s “VLN King” and “VLN Menthol King” combusted, filtered cigarettes as modified risk tobacco products (MRTPs), which help reduce exposure to, and consumption of, nicotine for smokers who use them. These are the first combusted cigarettes to be authorized as MRTPs and the second

    12/23/21 9:06:12 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    FDA Approval for KORSUVA issued to CARA THERAPEUTICS INC

    Submission status for CARA THERAPEUTICS INC's drug KORSUVA (ORIG-1) with active ingredient DIFELIKEFALIN has changed to 'Approval' on 08/23/2021. Application Category: NDA, Application Number: 214916, Application Classification: Type 1 - New Molecular Entity

    8/24/21 12:36:58 PM ET
    $CARA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CARA
    $CRBP
    $EAST
    $GENE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Gillin Ann Lefever

    4 - Village Farms International, Inc. (0001584549) (Issuer)

    4/21/26 4:23:56 PM ET
    $VFF

    SEC Form 3 filed by new insider Fell Donald G.

    3 - urban-gro, Inc. (0001706524) (Issuer)

    4/10/26 3:50:16 PM ET
    $UGRO
    Industrial Specialties
    Consumer Discretionary

    SEC Form 3 filed by new insider Sherb Eric Michael

    3 - urban-gro, Inc. (0001706524) (Issuer)

    4/9/26 6:17:37 PM ET
    $UGRO
    Industrial Specialties
    Consumer Discretionary

    $CARA
    $CRBP
    $EAST
    $GENE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Chief Executive Officer Degiglio Michael A bought $30,150 worth of shares (25,000 units at $1.21), increasing direct ownership by 0.26% to 9,783,127 units (SEC Form 4)

    4/A - Village Farms International, Inc. (0001584549) (Issuer)

    6/3/25 9:00:14 PM ET
    $VFF

    Chief Financial Officer Degiglio Michael A bought $30,150 worth of shares (25,000 units at $1.21), increasing direct ownership by 0.26% to 9,783,127 units (SEC Form 4)

    4 - Village Farms International, Inc. (0001584549) (Issuer)

    6/2/25 6:17:22 AM ET
    $VFF

    Chief Financial Officer Ruffini Stephen C bought $30,150 worth of shares (25,000 units at $1.21), increasing direct ownership by 0.26% to 9,783,127 units (SEC Form 4)

    4 - Village Farms International, Inc. (0001584549) (Issuer)

    6/2/25 6:12:58 AM ET
    $VFF

    $CARA
    $CRBP
    $EAST
    $GENE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Village Farms Celebrates Historic U.S. Cannabis Rescheduling

    Company applauds the Trump administration's commitment to delivering on its promises to the American people Village's efforts to ensure a transparent administrative process in 2025 contribute to landmark order Company looks forward to opportunity to activate its U.S. assets once permissible by all regulatory authorities LAKE MARY, Fla., April 23, 2026 (GLOBE NEWSWIRE) -- Village Farms International, Inc. ("Village Farms" or the "Company") (NASDAQ:VFF) today celebrated the rescheduling of marijuana from Schedule I to Schedule III of the Controlled Substances Act, the most significant shift in U.S. federal cannabis policy in generations. The action, signed by Acting Attorney General Todd

    4/23/26 4:30:00 PM ET
    $VFF

    22nd Century Group Expands Reduced Nicotine Platform Through New Testing Services Agreement with North Carolina State University

    MOCKSVILLE, N.C., April 23, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NASDAQ:XXII), a tobacco products company focused on nicotine reduction and plant biotechnology, today announced corporate updates regarding a new testing services agreement with North Carolina State University aimed at validating tobacco varieties featuring improved leaf quality and increased crop yields with the same low-nicotine content. The initiative builds upon 22nd Century's proprietary reduced nicotine content technology platform, which utilizes advanced plant breeding and biotechnology to reduce nicotine content in tobacco to minimally addictive levels. The Company's reduced nicotine tobacco is the foun

    4/23/26 7:50:00 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    urban-gro, Inc. (Nasdaq: UGRO) — Sri Lanka Cricket Confirms July 10 – August 5, 2026 and Four Venues for Lanka Premier League Season 6; Tournament Conducted in Partnership with UGRO Subsidiary IPG Group

    LAFAYETTE, Colo., April 23, 2026 (GLOBE NEWSWIRE) -- urban-gro, Inc. (NASDAQ:UGRO) ("urban-gro" or the "Company"), operating through Flash Sports & Media, Inc., today noted the official announcement by Sri Lanka Cricket ("SLC") confirming the dates, venues, and player-registration timeline for Lanka Premier League ("LPL") Season 6. The tournament will run from July 10 to August 5, 2026, and is owned by SLC and conducted in partnership with Innovative Production Group FZ, LLC ("IPG"), the event rights holder. The Company participates in the tournament through its subsidiary, IPG under existing commercial arrangements. Season 6 — By the Numbers Tournament windowJuly 10 – August 5, 2026 (

    4/23/26 7:05:00 AM ET
    $UGRO
    Industrial Specialties
    Consumer Discretionary

    $CARA
    $CRBP
    $EAST
    $GENE
    SEC Filings

    View All

    urban-gro Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

    8-K - urban-gro, Inc. (0001706524) (Filer)

    4/24/26 4:57:52 PM ET
    $UGRO
    Industrial Specialties
    Consumer Discretionary

    Amendment: SEC Form 10-K/A filed by urban-gro Inc.

    10-K/A - urban-gro, Inc. (0001706524) (Filer)

    4/21/26 4:32:00 PM ET
    $UGRO
    Industrial Specialties
    Consumer Discretionary

    SEC Form DEFA14A filed by Corbus Pharmaceuticals Holdings Inc.

    DEFA14A - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Filer)

    4/16/26 4:22:15 PM ET
    $CRBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CARA
    $CRBP
    $EAST
    $GENE
    Leadership Updates

    Live Leadership Updates

    View All

    urban-gro, Inc. (Nasdaq: UGRO) — Sri Lanka Cricket Confirms July 10 – August 5, 2026 and Four Venues for Lanka Premier League Season 6; Tournament Conducted in Partnership with UGRO Subsidiary IPG Group

    LAFAYETTE, Colo., April 23, 2026 (GLOBE NEWSWIRE) -- urban-gro, Inc. (NASDAQ:UGRO) ("urban-gro" or the "Company"), operating through Flash Sports & Media, Inc., today noted the official announcement by Sri Lanka Cricket ("SLC") confirming the dates, venues, and player-registration timeline for Lanka Premier League ("LPL") Season 6. The tournament will run from July 10 to August 5, 2026, and is owned by SLC and conducted in partnership with Innovative Production Group FZ, LLC ("IPG"), the event rights holder. The Company participates in the tournament through its subsidiary, IPG under existing commercial arrangements. Season 6 — By the Numbers Tournament windowJuly 10 – August 5, 2026 (

    4/23/26 7:05:00 AM ET
    $UGRO
    Industrial Specialties
    Consumer Discretionary

    urban-gro, Inc. (Nasdaq: UGRO) Announces Lanka Premier League Season 6 — Potential Record 600-Player Pool, World-Class Marquee Talent, and Expected Appointment of Chris Gayle as Global Brand Ambassador

    LAFAYETTE, Colo., April 13, 2026 (GLOBE NEWSWIRE) -- urban-gro, Inc. (NASDAQ:UGRO) ("urban-gro" or the "Company"), operating through Flash Sports & Media, Inc., a vertically integrated sports, media, and experiential platform, today announced that Lanka Premier League ("LPL") Season 6 — executed via its subsidiary Innovative Production Group FZ, LLC ("IPG") platform — is expecting record-breaking expansion. Season 6 is projected to feature the largest-ever LPL player registration pool of 500 to 600 athletes expected to be drawn from the world's top cricketing nations, elevated by a marquee roster of global superstars and the expected appointment of T20 legend Chris Gayle as official Brand

    4/13/26 7:05:00 AM ET
    $UGRO
    Industrial Specialties
    Consumer Discretionary

    Greenlane Reports Fourth Quarter and Full Year 2025 Financial Results

    BOCA RATON, Fla., March 31, 2026 (GLOBE NEWSWIRE) -- Greenlane Holdings, Inc. ("Greenlane" or the "Company") (NASDAQ:GNLN), a publicly traded digital asset treasury company focused on the acquisition, management, and strategic deployment of BERA, the native token of the Berachain blockchain network, today reported its financial results for the fourth quarter and full year ended December 31, 2025. Digital Asset Treasury Strategy In October 2025, following the closing of a private placement that raised $110.7M in capital, Greenlane adopted a Treasury Policy and initiated a strategic shift toward a digital asset treasury strategy focused on BERA, the native token of the Berachain blockchain

    3/31/26 5:01:24 PM ET
    $GNLN
    Durable Goods
    Consumer Discretionary

    $CARA
    $CRBP
    $EAST
    $GENE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by 22nd Century Group Inc.

    SC 13G/A - 22nd Century Group, Inc. (0001347858) (Subject)

    12/3/24 11:18:54 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    Amendment: SEC Form SC 13G/A filed by Corbus Pharmaceuticals Holdings Inc.

    SC 13G/A - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Subject)

    11/14/24 7:48:14 PM ET
    $CRBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Corbus Pharmaceuticals Holdings Inc.

    SC 13G - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Subject)

    11/14/24 6:41:20 PM ET
    $CRBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CARA
    $CRBP
    $EAST
    $GENE
    Financials

    Live finance-specific insights

    View All

    22nd Century Group Reports Fourth Quarter and Full Year 2025 Financial Results

    VLN® Commercial Expansion Drives Continued Shift Toward Higher Margin Proprietary Branded Products Expanding VLN® Store Counts and State Authorizations Increase Availability of Smoking Harm Reduction Products MOCKSVILLE, N.C., March 26, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NASDAQ:XXII), the only tobacco products company focused on reducing the harms of smoking through nicotine reduction, today announced results for the fourth quarter and fiscal year-ended December 31, 2025, and provided an update on recent business highlights. The Company's proprietary low nicotine technology is designed to serve adult smokers who want to change their smoking habits by significantly reduci

    3/26/26 6:00:00 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    Village Farms Delivers Record Full Year 2025 Profitability with Continued Strong Performance in Q4

    Record Full Year Consolidated Net Income from Continuing Ops of $21.0 Million or $0.19 Per Share, Adjusted EBITDA from Continuing Ops of $49.9 Million, and Operating Cash Flow of $58.1 MillionConsolidated Q4 Net Sales Increased 9% YoY to $49.6 Million; Canadian Cannabis Sales Increased 10% YoY; International Export Cannabis Sales Increased 384% YoYConsolidated Q4 Net Income from Continuing Ops of $2.3 Million or $0.02 Per Share, Adj. EBITDA from Continuing Ops of $8.6 Million, and Operating Cash Flow of $11.4 MillionCanadian Cannabis Delivers Q4 Gross Margin of 43%; Adj. EBITDA of $9.8 Million or 25.8% of Sales All Expansion Projects Remain on Time and Under Budget; Delta 2 Expansion Commenc

    3/12/26 7:00:00 AM ET
    $VFF

    Village Farms International to Report Q4 and Full Year 2025 Results on March 12, 2026

    VANCOUVER, British Columbia, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Village Farms International, Inc. ("Village Farms" or the "Company") (NASDAQ:VFF) today announced it will host a conference call to discuss its fourth quarter and full year 2025 financial results on Thursday, March 12, 2026, at 8:30 a.m. ET. Participants can access the conference call via a webcast at Village Farms Fourth Quarter 2025 Conference Call Webcast or on the Company website at Village Farms - Events. Participants wanting to access the conference call by telephone must register in advance at Village Farms Fourth Quarter 2025 Conference Call Registration to receive telephone dial-in information. The live question and a

    2/26/26 4:30:00 PM ET
    $VFF

    $CARA
    $CRBP
    $EAST
    $GENE
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at urban-gro Inc. on Jun 6

    Urban-gro Inc. saw an interesting insider purchase on June 6, 2024, when Wilks Lewis bought $29,000 worth of shares, acquiring 20,000 units at a price of $1.45 per unit. This transaction increased Lewis' direct ownership by 12% to 184,108 units, as reported in SEC Form 4. Insider transactions like this can provide valuable insights for investors, indicating confidence in the company's future prospects. Analyzing the insider activity surrounding Urban-gro Inc., we can observe several transactions that may reveal patterns or insights. Looking back at previous filings, on September 1, 2023, Wilks Lewis purchased $10,300 worth of shares, acquiring 10,000 units at $1.03 per unit. This

    6/10/24 12:49:49 AM ET
    $UGRO
    Industrial Specialties
    Consumer Discretionary